MENU
+Compare
HTEC
ETF ticker: NYSE ARCA
AS OF
Sep 26 closing price
Price
$30.14
Change
+$0.27 (+0.90%)
Net Assets
45.88M

HTEC stock forecast, quote, news & analysis

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index... Show more

Category: #Health
HTEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for HTEC with price predictions
Sep 26, 2025

HTEC in upward trend: price may jump up because it broke its lower Bollinger Band on September 25, 2025

HTEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where HTEC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 50-day moving average for HTEC moved above the 200-day moving average on August 20, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HTEC advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 251 cases where HTEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HTEC moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HTEC as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HTEC turned negative on September 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HTEC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Incyte Corp (NASDAQ:INCY), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

Market Cap

The average market capitalization across the Robo Global® Hlthcare Tech & Innovt ETF ETF is 29.55B. The market cap for tickers in the group ranges from 197.05M to 232.44B. ABT holds the highest valuation in this group at 232.44B. The lowest valued company is HCAT at 197.05M.

High and low price notable news

The average weekly price growth across all stocks in the Robo Global® Hlthcare Tech & Innovt ETF ETF was -2%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was 10%. GRAL experienced the highest price growth at 20%, while NOVT experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Robo Global® Hlthcare Tech & Innovt ETF ETF was -51%. For the same stocks of the ETF, the average monthly volume growth was 12% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 64
Price Growth Rating: 58
SMR Rating: 73
Profit Risk Rating: 85
Seasonality Score: -43 (-100 ... +100)
View a ticker or compare two or three
HTEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
3555 Northwest 58th StreetSuite 410Oklahoma City
Phone
+1 405 7788377
Web
www.exchangetradedconcepts.com